Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency

Vote: Final vote
Decision: No. 32 of the sitting of 10 Apr 2024
Result: 488 for · 67 against · 34 abstained Adopted · roll call
Date: 10 April 2024, 19:23

More facts (6)

Effect: Passed — this vote decided the decision
Position: vote 40 of 40 on the decision
Official label: A9-0141/2024 – Tiemo Wölken – Commission proposal
Text: Report A-9-2024-0141
Dossier: 2023-0131
Vote id: 166879

Effect: Passed — this vote decided the decision
Position: vote 40 of 40 on the decision
Official label: A9-0141/2024 – Tiemo Wölken – Commission proposal
Text: Report A-9-2024-0141
Dossier: 2023-0131
Vote id: 166879

Cite this page

The members file includes members in office who did not vote.

Roll-call results (EP)

Link to this page

Result

The vote as recorded by name.

Adopted · 83 % of the votes cast were for.

This was the final vote on the decision: Passed.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
EPP	For 75	Against 1	Abst. 1	Majority line For	Clear line For
S&D	For 57	Against 1	Abst. 0	Majority line For	Clear line For
Renew	For 38	Against 0	Abst. 0	Majority line For	Clear line For
Greens	For 27	Against 1	Abst. 0	Majority line For	Clear line For
The Left	For 5	Against 6	Abst. 1	Majority line Against	Clear line Divided
Patriots	For 6	Against 15	Abst. 5	Majority line Against	Clear line Divided
ECR	For 15	Against 10	Abst. 0	Majority line For	Clear line Divided
No group	For 3	Against 2	Abst. 0	Majority line —	Clear line No line
ESN	For 0	Against 4	Abst. 0	Majority line Against	Clear line Against

Countries × groups

How each country’s members of each group voted.

The breakdown by country is not available right now.

Members

Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 589 members

No vote recorded

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

The list of members without a recorded position is not available right now.

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Similar votes are not available right now.

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

No connections found for this vote.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/votes/2024-04-10/166879
Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament)
Results of votes, sitting of 10 April 2024 (European Parliament)
Data source: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Final vote — Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency”. Vote, 10 April 2024. votingId 166879, reference 2023-0131. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2024-04-10/166879 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-vote-2024-04-10-166879,
  author = {{European Parliament}},
  title = {{Final vote — Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency}},
  year = {2024},
  date = {2024-04-10},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2024-04-10/166879}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2024-04-10/166879},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 166879, reference 2023-0131. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}